Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours
{{output}}
Objective: Somatostatin receptor analogues are well-established in the treatment of metastatic gastro-enteropancreatic neuroendocrine tumours (GEP-NETs), especially for symptom control in patients with the carcinoid syndrome, and... ...
